See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Equity Residential (EQR) - free report >>
Freshpet, Inc. (FRPT) - free report >>
Jazz Pharmaceuticals PLC (JAZZ) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Equity Residential (EQR) - free report >>
Freshpet, Inc. (FRPT) - free report >>
Jazz Pharmaceuticals PLC (JAZZ) - free report >>
Image: Shutterstock
New Strong Sell Stocks for March 23rd
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Baozun Inc. (BZUN - Free Report) provides e-commerce solutions to brand partners. The Zacks Consensus Estimate for its current year earnings has been revised nearly 29% downward over the last 30 days.
Equity Residential (EQR - Free Report) is focused on the acquisition, development and management of residential properties. The Zacks Consensus Estimate for its current year earnings has been revised 4.5% downward over the last 30 days.
Freshpet, Inc. (FRPT - Free Report) manufactures and markets natural fresh meals and treats for dogs and cats. The Zacks Consensus Estimate for its current year earnings has been revised 31.6% downward over the last 30 days.
Jazz Pharmaceuticals plc (JAZZ - Free Report) is a biopharmaceutical company that identifies, develops and commercializes pharmaceutical products for various unmet medical needs. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days.
SpartanNash Company (SPTN - Free Report) distributes and retails grocery products. The Zacks Consensus Estimate for its current year earnings has been revised 15.2% downward over the last 30 days.
View the entire Zacks Rank #5 List.